717 related articles for article (PubMed ID: 17688074)
1. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
[TBL] [Abstract][Full Text] [Related]
3. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
Nehra A; Blute ML; Barrett DM; Moreland RB
Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
[TBL] [Abstract][Full Text] [Related]
4. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
Raina R; Pahlajani G; Agarwal A; Zippe CD
BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385
[TBL] [Abstract][Full Text] [Related]
5. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
Sperling H; Lümmen G; Schneider T; Rübben H
Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of transurethral application of alprostadil for erectile dysfunction in Indonesians.
Pangkahila WI
Asian J Androl; 2000 Sep; 2(3):233-6. PubMed ID: 11225984
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy.
Costabile RA; Spevak M; Fishman IJ; Govier FE; Hellstrom WJ; Shabsigh R; Nemo KJ; Rapport JL; Tam PY; Weldon KL; Gesundheit N
J Urol; 1998 Oct; 160(4):1325-8. PubMed ID: 9751346
[TBL] [Abstract][Full Text] [Related]
8. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.
Padma-Nathan H; Hellstrom WJ; Kaiser FE; Labasky RF; Lue TF; Nolten WE; Norwood PC; Peterson CA; Shabsigh R; Tam PY; Place VA; Gesundheit N
N Engl J Med; 1997 Jan; 336(1):1-7. PubMed ID: 8970933
[TBL] [Abstract][Full Text] [Related]
9. [Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction].
Amar E
Contracept Fertil Sex; 1999; 27(7-8):548-52. PubMed ID: 10495573
[TBL] [Abstract][Full Text] [Related]
10. MUSE therapy: preliminary clinical observations.
Werthman P; Rajfer J
Urology; 1997 Nov; 50(5):809-11. PubMed ID: 9372900
[TBL] [Abstract][Full Text] [Related]
11. Intraurethral application of alprostadil in patients with failed inflatable penile prosthesis.
Benevides MD; Carson CC
J Urol; 2000 Mar; 163(3):785-7. PubMed ID: 10687977
[TBL] [Abstract][Full Text] [Related]
12. Emerging oral drugs for erectile dysfunction.
Briganti A; Salonia A; Gallina A; Suardi N; Rigatti P; Montorsi F
Expert Opin Emerg Drugs; 2004 May; 9(1):179-89. PubMed ID: 15155143
[TBL] [Abstract][Full Text] [Related]
13. Acceptance, efficacy and preference of Sildenafil in patients on long term auto-intracavernosal therapy: a study with follow-up at one year.
Buvat J; Lemaire A; Ratajczyk J
Int J Impot Res; 2002 Dec; 14(6):483-6. PubMed ID: 12494282
[TBL] [Abstract][Full Text] [Related]
14. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy: medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy.
Raina R; Nandipati KC; Agarwal A; Mansour D; Kaelber DC; Zippe CD
J Androl; 2005; 26(6):757-60. PubMed ID: 16291971
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group.
Linet OI; Ogrinc FG
N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic efficacy for ED patients treated with low dosage of PGE1].
Zhao D; Zhang B; Ou RB; Liao B; Chen YX; Lu AH; Wan ST; Lu MQ
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):48-50. PubMed ID: 12680333
[TBL] [Abstract][Full Text] [Related]
18. New treatment options for erectile dysfunction in patients with diabetes mellitus.
Basu A; Ryder RE
Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
[TBL] [Abstract][Full Text] [Related]
19. Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
La Vignera S; Calogero AE; Cannizzaro MA; Condorelli R; Noto Z; Vicari E
Minerva Endocrinol; 2006 Dec; 31(4):251-61. PubMed ID: 17213792
[TBL] [Abstract][Full Text] [Related]
20. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study.
Shabsigh R; Padma-Nathan H; Gittleman M; McMurray J; Kaufman J; Goldstein I
Urology; 2000 Jan; 55(1):109-13. PubMed ID: 10654905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
